Details about Margaret E. Blume-Kohout

Access statistics for papers by Margaret E. Blume-Kohout.

Last updated 2023-11-07. Update your information in the RePEc Author Service.

Short-id: pbl113

Working Papers

2009

1. Federal Life Sciences Funding and University R&D
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (13)

2008

2. The Impact of Medicare Part D on Pharmaceutical R&D
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)

Journal Articles

2024

1. Entrepreneurship Lock and the Demand for Health Insurance: Evidence from the US Affordable Care Act
   ILR Review, 2024, 77, (2), 199-226

2023

2. The Affordable Care Act and Women’s Self-Employment in the United States
   Feminist Economics, 2023, 29, (1), 174-204
3. The case of the interrupting funder: dynamic effects of R&D funding and patenting in U.S. universities
   The Journal of Technology Transfer, 2023, 48, (4), 1221-1242

2022

4. Incentivizing STEM participation: Evidence from the SMART Grant Program
   Southern Economic Journal, 2022, 89, (2), 373-405

2017

5. The University and the Economyby Aldo Geuna and Federica Rossi
   Science and Public Policy, 2017, 44, (1), 147-148

2016

6. Training the scientific workforce: Does funding mechanism matter?
   Research Policy, 2016, 45, (6), 1291-1303 View citations (10)
7. Why are some foreign-born workers more entrepreneurial than others?
   The Journal of Technology Transfer, 2016, 41, (6), 1327-1353 View citations (4)

2015

8. The effect of federal research funding on formation of university-firm biopharmaceutical alliances
   The Journal of Technology Transfer, 2015, 40, (5), 859-876 View citations (4)
9. University R&D Funding Strategies in a Changing Federal Funding Environment
   Science and Public Policy, 2015, 42, (3), 355-368 View citations (7)

2013

10. Are Graduate Students Rational? Evidence from the Market for Biomedical Scientists
    PLOS ONE, 2013, 8, (12), 1-13 View citations (5)
11. Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development
    Journal of Public Economics, 2013, 97, (C), 327-336 View citations (81)

2012

12. Does Targeted, Disease‐Specific Public Research Funding Influence Pharmaceutical Innovation?
    Journal of Policy Analysis and Management, 2012, 31, (3), 641-660 View citations (17)